- Home
- NBHC vs NVCR Comparison
NBHC vs NVCR Comparison
Compare NBHC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBHC | NVCR |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | 1488 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NBHC | NVCR |
|---|---|---|
| Price | $39.70 | $13.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $44.33 | $28.42 |
| AVG Volume (30 Days) | 308.4K | ★ 1.8M |
| Earning Date | 01-21-2026 | 10-30-2025 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.15 | N/A |
| Revenue | $405,867,000.00 | ★ $642,269,000.00 |
| Revenue This Year | $8.48 | $9.75 |
| Revenue Next Year | $28.10 | $5.62 |
| P/E Ratio | $12.67 | ★ N/A |
| Revenue Growth | 1.03 | ★ 11.17 |
| 52 Week Low | $32.83 | $10.70 |
| 52 Week High | $47.11 | $34.13 |
Technical Indicators
Market Signals| Indicator | NBHC | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 69.14 | 60.37 |
| Support Level | $38.45 | $10.79 |
| Resistance Level | $40.22 | $13.94 |
| Average True Range (ATR) | 0.72 | 0.61 |
| MACD | 0.27 | 0.22 |
| Stochastic Oscillator | 88.67 | 80.48 |
Price Performance
Historical ComparisonAbout NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.